EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fifteen Years after the Definition of Trypanosoma cruzi DTUs: What Have We Learned?

Bianca Zingales iD, Andréa M Macedo

Life · 14.12.2023 · 13 (12) · 2339

DOI: 10.3390/life13122339 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 14.12.2023. Verfasst von Bianca Zingales und 1 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-900, São Paulo, Brazil. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa de Minas Gerais (FAPEMIG).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trypanosoma cruzi, the protozoan causative of Chagas disease (ChD), exhibits striking genetic and phenotypic intraspecific diversity, along with ecoepidemiological complexity. Human-pathogen interactions lead to distinct clinical presentations of ChD. In 2009, an international consensus classified T. cruzi strains into six discrete typing units (DTUs), TcI to TcVI, later including TcBat, and proposed reproducible genotyping schemes for DTU identification. This article aims to review the impact of classifying T. cruzi strains into DTUs on our understanding of biological, ecoepidemiological, and pathogenic aspects of T. cruzi. We will explore the likely origin of DTUs and the intrinsic characteristics of each group of strains concerning genome organization, genomics, and susceptibility to drugs used in ChD treatment. We will also provide an overview of the association of DTUs with mammalian reservoirs, and summarize the geographic distribution, and the clinical implications, of prevalent specific DTUs in ChD patients. Throughout this review, we will emphasize the crucial roles of both parasite and human genetics in defining ChD pathogenesis and chemotherapy outcome.

Schlagwörter

Stichwörter der Autor:innen

Chagas disease manifestationsTrypanosoma cruzidiscrete typing unitsecoepidemiologygenomics

Autor:innen und Institutionen

  • Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-900, São Paulo, Brazil.
  • Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Minas Gerais, Brazil.

ORCID-Profile: Bianca Zingales

Förderung

  • National Council for Scientific and Technological Development
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Fundação de Amparo à Pesquisa de Minas Gerais (FAPEMIG)

Zitieren

APA

Zingales, B., & Macedo, A. M. (2023). Fifteen Years after the Definition of Trypanosoma cruzi DTUs: What Have We Learned?. Life, 13(12), 2339. https://doi.org/10.3390/life13122339

Vancouver

Zingales B, Macedo AM. Fifteen Years after the Definition of Trypanosoma cruzi DTUs: What Have We Learned?. Life. 2023;13(12):2339. doi:10.3390/life13122339

BibTeX
@article{Zingales2023,
  author = {Zingales, Bianca and Macedo, Andréa M},
  title = {Fifteen Years after the Definition of Trypanosoma cruzi DTUs: What Have We Learned?},
  journal = {Life},
  year = {2023},
  volume = {13},
  number = {12},
  pages = {2339},
  doi = {10.3390/life13122339}
}
Kostenlos starten →